Albemarle Corporation
Rank #463StartupALB · NYSE · Basic Materials
Albemarle Corporation (ALB) — Rank #463 by gross profitability (GP/assets 0.04) · ROE -5.0% · Piotroski F-Score 5 / 9.
As-of 2026-09-15 · CIK 0000915913 · all metrics point-in-time as of the filing date.
About
Albemarle Corporation provides energy storage solutions worldwide.
Show moreShow less
It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries.
Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
- Industry
- Specialty Chemicals
- Sector
- Basic Materials
- State
- VA
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- albemarle.com
Price History
Company Snapshot
P/S is the primary valuation lens for pre-profit companies.
Market Cap
$13.36B
P/E (annual)
—
P/S (annual)
2.6
P/B
1.3
P/OCF (annual)
10.4
Shareholder Yield
1.3%
Employees
7,800
Industry
Specialty Chemicals
Exchange
NYSE
Signal Flags
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
3/3 passGrowth
1/2 passTerry Smith quality gate
Passes 0/5 Terry Smith thresholds2 of 5 thresholds not computable from filed data.
What Growth Is Priced In
Implied revenue growth (10Y)
7.2%
The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).
Dilution drag: 0.1% — per-share value needs a total required return of 7.3% once share-count change is priced in.
vs. own 6-year median revenue growth: 1.0%
priced above its own historyCost-of-equity sensitivity (implied growth at different discount rates)
r = 8%
2.9%
r = 10% (base)
7.2%
r = 12%
10.9%
Net debt / market cap: -6.5%
Note: current FCF margin is 1.8σ above its historical mean — implied growth may understate valuation risk if the margin reverts.
Valuation History
Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.
P / E
Price / diluted EPS
P / S
Price / revenue per share
P / B
Price / book value per share
P / GP
Price / gross profit per share
P / FCF
Price / free cash flow per share
Earnings bubble check
Current margins may be above sustainable levels — a P/E based on peak earnings can overstate cheapness.
Burn rate (cash flow) is the primary read at this stage — TAM and product-market fit aren't metrics this dashboard tracks.
Profitability
Gross profitability (GP / assets)
0.04
Primary signal (Novy-Marx).
3rd pctl of 34 SIC 28 peers
Return on equity
-5.0%
Gross margin
13.0%
6th pctl of 34 SIC 28 peers
Revenue growth (YoY)
-4.4%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
-11.1%
Revenue CAGR (5Y)
10.4%
Earnings CAGR (3Y)
—
FCF CAGR (3Y)
2.3%
Anti-fragile safety
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
0.51
73rd pctl of 31 SIC 28 peers (best = lowest)
Current ratio
2.09×
45th pctl of 34 SIC 28 peers
Quick ratio
1.18×
Net cash
$864.14M
Cash & equivalents minus total debt.
Cash-flow health
Free cash flow
$692.47M
Operating cash flow minus capex.
Positive free cash flow
FCF / net income
2.36
Cash-backing of earnings.
FCF/NI divergence
Unfavorable divergence (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
0.8%
Stock-based comp intensity.
Dividend safety
Composite score
3.0 / 5
Piotroski F-Score
F-Score
5 / 9
Fundamental-strength score (0-9).
Lifecycle Phase History
Lynch sell alert: Turnaround stalled
Classified startup for 2 consecutive fiscal years (2024-12-31, 2025-12-31) with no recovery to a healthier phase -- Lynch's turnaround rule: if it hasn't turned around by now, assume it isn't going to.